Evidence map›Paper›PMID 29097652›Full record

ArticleNature communications2017

Spermine synthase deficiency causes lysosomal dysfunction and oxidative stress in models of Snyder-Robinson syndrome.

Chong Li, Jennifer M Brazill, Sha Liu, Christofer Bello, Yi Zhu, Marie Morimoto, Lauren Cascio, Rini Pauly, Zoraida Diaz-Perez, May Christine V Malicdan and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Polyamine Metabolism in Brain Health and Disease.Neuropharmacology and therapy · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Chong LiDepartment of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.ORCID http://orcid.org/0000-0003-2823-7360
Jennifer M BrazillDepartment of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Sha LiuSchool of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, 264005, China.
Christofer BelloDepartment of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Yi ZhuDepartment of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Marie MorimotoNIH Undiagnosed Diseases Program, National Human Genome Research Institute, NIH, Bethesda, MD, 20892, USA.
Lauren CascioJC Self Research Institute, Greenwood Genetic Center, Greenwood, SC, 29646, USA.
Rini PaulyJC Self Research Institute, Greenwood Genetic Center, Greenwood, SC, 29646, USA.
Zoraida Diaz-PerezDepartment of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
May Christine V MalicdanNIH Undiagnosed Diseases Program, National Human Genome Research Institute, NIH, Bethesda, MD, 20892, USA.ORCID http://orcid.org/0000-0003-1697-6959
Hongbo WangSchool of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, 264005, China.
Luigi BoccutoJC Self Research Institute, Greenwood Genetic Center, Greenwood, SC, 29646, USA.
Charles E SchwartzJC Self Research Institute, Greenwood Genetic Center, Greenwood, SC, 29646, USA.
William A GahlNIH Undiagnosed Diseases Program, National Human Genome Research Institute, NIH, Bethesda, MD, 20892, USA.
Cornelius F BoerkoelNIH Undiagnosed Diseases Program, National Human Genome Research Institute, NIH, Bethesda, MD, 20892, USA.
R Grace ZhaiDepartment of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA. gzhai@med.miami.edu.ORCID http://orcid.org/0000-0002-7599-1430
University of Miami · USGreenwood Genetic Center · USNational Human Genome Research Institute · USYantai University · CNUniversity of British Columbia · CA

Funding

Functional Interaction of GBAS and SLC41A2 in Drosophila models for UDP_755R21GM119018 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZHAI, RONG GRACE · 2016 to 2019
$675k
NHGRI NIH HHS HHSN268201300038CNHGRI NIH HHS HHSN268201400033CNIGMS NIH HHS R21 GM119018
6 · The paper itself

Abstract

Polyamines are tightly regulated polycations that are essential for life. Loss-of-function mutations in spermine synthase (SMS), a polyamine biosynthesis enzyme, cause Snyder-Robinson syndrome (SRS), an X-linked intellectual disability syndrome; however, little is known about the neuropathogenesis of the disease. Here we show that loss of dSms in Drosophila recapitulates the pathological polyamine imbalance of SRS and causes survival defects and synaptic degeneration. SMS deficiency leads to excessive spermidine catabolism, which generates toxic metabolites that cause lysosomal defects and oxidative stress. Consequently, autophagy-lysosome flux and mitochondrial function are compromised in the Drosophila nervous system and SRS patient cells. Importantly, oxidative stress caused by loss of SMS is suppressed by genetically or pharmacologically enhanced antioxidant activity. Our findings uncover some of the mechanisms underlying the pathological consequences of abnormal polyamine metabolism in the nervous system and may provide potential therapeutic targets for treating SRS and other polyamine-associated neurological disorders.

Indexed as

AnimalsAnimals, Genetically ModifiedAntioxidantsAutophagyBrainDisease Models, AnimalDrosophila melanogasterDrosophila ProteinsElectron Transport Complex IVElectroretinographyHumansLysosomesMicroscopy, Electron, TransmissionOxidative StressPolyaminesReactive Oxygen SpeciesAntioxidantsDrosophila ProteinsElectron Transport Complex IVPolyaminesReactive Oxygen SpeciesSpermidineSpermine Synthase

Identifiers

PMID29097652
PMCPMC5668419
OpenAlexW2765345893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.